Biotron is preparing a ***detailed briefing package to submit to the FDA during the first quarter of 2022. Guidance from the FDA will inform the final design of a suitable international trial and will be a key component of outreach to **potential partners. **potential partners are what they have been .... *** they're preparing detailed package in that they're confident to move forward with FDA guidance...
BIT Price at posting:
6.9¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)